An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine

Vaccine
B Y LeeDarin Zehrung

Abstract

New vaccine technologies may improve the acceptability, delivery (potentially enabling self-administration), and product efficacy of influenza vaccines. One such technology is the microneedle patch (MNP), a skin delivery technology currently in development. Although MNPs hold promise in preclinical studies, their potential economic and epidemiologic impacts have not yet been evaluated. We utilized a susceptible-exposed-infectious-recovered (SEIR) transmission model linked to an economic influenza outcomes model to assess the economic value of introducing the MNP into the current influenza vaccine market in the United States from the third-party payer and societal perspectives. We also explored the impact of different vaccination settings, self-administration, the MNP price, vaccine efficacy, compliance, and MNP market share. Outcomes included costs, quality-adjusted life years (QALYs), cases, and incremental cost-effectiveness ratios (ICERs; cost/QALY). With healthcare provider administration, MNP introduction would be cost-effective (ICERs ≤$23,347/QALY) at all MNP price points ($9.50-$30) and market shares (10-60%) assessed, except when compliance and efficacy were assumed to be the same as existing vaccines and the MNP occup...Continue Reading

References

Jun 22, 1996·Lancet·C Chadwick, B A Oppenheim
Oct 9, 1996·JAMA : the Journal of the American Medical Association·L B RussellM C Weinstein
Mar 28, 2001·The American Journal of the Medical Sciences·M D NettlemanC Chafin
Oct 4, 2002·The American Journal of Medicine·Kenneth J Smith, Mark S Roberts
Apr 24, 2004·The Journal of Infectious Diseases·Fangjun ZhouMary M McCauley
Oct 7, 2004·Pediatrics·Celeste Ojeda Hemingway, Katherine A Poehling
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy F JonesWilliam Schaffner
Jan 11, 2005·The American Journal of Medicine·Michael B Rothberg, David N Rose
Sep 15, 2005·Archives of Internal Medicine·Peng-Jun LuCarolyn Buxton Bridges
Oct 17, 2006·American Family Physician·Steven E Roskos
Feb 1, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Amanda Banks ChristiniKarin E Byers
Feb 6, 2007·American Journal of Infection Control·Bayo C Willis, Pascale Wortley
Jun 5, 2007·Vaccine·Noelle-Angelique M MolinariCarolyn B Bridges
Jan 31, 2008·American Journal of Epidemiology·Fabrice CarratAlain-Jacques Valleron
Oct 15, 2008·PharmacoEconomics·Martin Keech, Paul Beardsworth
Feb 24, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Sandra E TalbirdBeate Sander
Apr 28, 2009·The Lancet Infectious Diseases·Justin LesslerDerek A T Cummings
Sep 30, 2009·Vaccine·Bruce Y LeeKenneth J Smith
Jan 9, 2010·Pediatrics·Judith E GlaznerStephen Berman
Jan 9, 2010·Pediatrics·Byung-Kwang YooMargaret S Coleman
Dec 22, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniella J PerlrothDouglas K Owens
Mar 24, 2010·The Pediatric Infectious Disease Journal·Mandy A AllisonCarrie L Byington
Jul 20, 2010·Nature Medicine·Sean P SullivanMark R Prausnitz
Sep 24, 2010·Human Vaccines·Bruce Y Lee, Sarah M McGlone
Oct 5, 2010·Vaccine·Kenneth J SmithRichard K Zimmerman
Mar 15, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Bruce Y LeeMichael M Wagner
Sep 22, 2011·Influenza and Other Respiratory Viruses·Bruce Y LeeMichael M Wagner
Mar 28, 2012·Journal of Pain & Palliative Care Pharmacotherapy·UNKNOWN Centers for Disease Control and Prevention, Public Health Service, U.S. Department Health
Sep 28, 2012·MMWR. Morbidity and Mortality Weekly Report·UNKNOWN Centers for Disease Control and Prevention (CDC)
Oct 23, 2012·Vaccine·Bruce Y LeeAlyssa M Willig

❮ Previous
Next ❯

Citations

Sep 1, 2015·Vaccine·Marcel B M Teunissen, Darin Zehrung
Nov 26, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jaya Arya, Mark R Prausnitz
Apr 5, 2017·Annual Review of Chemical and Biomolecular Engineering·Mark R Prausnitz
Jun 12, 2018·Expert Review of Pharmacoeconomics & Outcomes Research·Jolanda Richter-JohnsonViness Pillay
Sep 12, 2018·Expert Opinion on Drug Delivery·Aoife M RodgersRyan F Donnelly
May 10, 2020·The Journal of Infectious Diseases·Sarah M BartschBruce Y Lee
May 7, 2020·The Pan African Medical Journal·Lauren Christine Richardson, William John Moss
Aug 5, 2017·Materials·Brendan KochHyo-Jick Choi
Apr 27, 2017·Transactions of the Royal Society of Tropical Medicine and Hygiene·D N Durrheim, J L Goodson
Jan 6, 2021·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Andi Dian PermanaRyan F Donnelly
Jan 12, 2021·Expert Review of Vaccines·Md Kamal HossainMajid Hassanzadeganroudsari
Feb 17, 2021·Drug Delivery and Translational Research·Yoo Chun KimMark R Prausnitz
Dec 27, 2016·Vaccine·Bruce Y LeeCarla G Tilchin
Mar 13, 2017·ACS Biomaterials Science & Engineering·Jordan A StinsonDavid L Kaplan
Aug 28, 2021·Therapeutic Advances in Vaccines and Immunotherapy·Michelle S LeeVinod E Nambudiri
Nov 23, 2021·Pharmaceutical Development and Technology·Thuy Trang NguyenGiau Van Vo

❮ Previous
Next ❯

Related Concepts